Degradation of extracellular matrix protein tenascin-C by cathepsin B: An interaction involved in the progression of gliomas

Biological Chemistry

Volumn 383, Issue 9, 2002, Pages 1407-1413

  Mai, Jianxin ^a   Sameni, Mansoureh ^a   Mikkelsen, Tom ^a   Sloane, Bonnie F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin; Cysteine protease; Glioma; Immunohistochemistry; Tenascin C

Indexed keywords

CATHEPSIN B; COLLAGEN TYPE 1; ENZYME PRECURSOR; FIBRIN; LIPOCORTIN 2; MATRIX PROTEIN; PROCATHEPSIN B; TENASCIN; TETRAMER; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER GROWTH; CANCER INVASION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MARKER; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR CELL CULTURE; BRAIN TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; WESTERN BLOTTING;

ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; CATHEPSIN B; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; TENASCIN;

EID: 0036754586     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.159     Document Type: Article

References (56)

1. Bourdon, M.A., and Ruoslahti, E. (1989). Tenascin mediates cell attachment through an RGD-dependent receptor. J. Cell Biol. 108, 1149-1155.
2. Broll, R., Meyer, S., Neuber, M., and Bruch, H-P. 1995). Expression of tenascin in tumors of the esophagus, small intestine and colo-rectum. Gen. Diagn. Pathol. 141, 111-119.
3. Brooks, P. C., Clark, R. F., and Cheresh, D. A. (1994). Requirement of vascular integrin αvβ3 for angiogenesis. Science 264, 569-571.
4. Castellani, P., Dorcaratto, A., Siri, A., Zardi, L., and Viale, G. L. (1995). Tenascin distribution in human brain tumors. Acta Neurochir. (Vienna) 136, 44-50.
5. Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., and Sakakura, T. (1986). Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131-139.
6. Chiquet-Ehrismann, R., Hagios, C., and Schenk, S. (1995). The complexity in regulating the expression of tenascins. Bioassays 17, 873-878.
7. Choi, K. S., Ghuman, J., Kassam, G., Kang, H. M., Fitzpatrick, S.L., and Waisman, D. M. (1998). Annexin II tetramer inhibits plasmin-dependent fibrinolysis. Biochemsitry 37, 648-655.
8. Chung, C. Y., and Erickson, H. P. (1994). Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J. Cell Biol. 126, 539-548.
9. DeClerck, Y. A., Imren, S., Montgomery, A. M., Mueller, B. M., Reisfeld, R. A., and Laug, W. E. (1997). Proteases and protease inhibitors in tumor progression. Adv. Exp. Med. Biol. 425, 89-97.
10. Denda, S., Muller, U., Crossin K. L., Erickson, H. P., and Reichardt, L. (1998). Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin α8β1 receptor interactions with tenascin: murine α8β1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. Biochemistry 37, 5464-5474.
11. d'Ortho, M. P., Will, H., Atkinson, S., Butler, G., Messent, A., Gavrilovic, J., Smith, B., Timpl, R., Zardi, L., and Murphy, G. (1997). Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757.
12. Emmert-Buck, M. R., Karustis, D. G., Day, N. A., Honn, K. V., and Sloane, B. F. (1992). Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 282, 273-278.
13. Emmert-Buck, M. R., Roth, M. J., Zhuang, Z., Campo, E., Rozhin, J., Sloane, B. F., Liotta, L. A., and Stetler-Stevenson, W. G. (1994). Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol. 145, 1285-1290.
14. Erickson, H. P. (1993). Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5, 869-876.
15. Erickson, H. P., and Bourdon, M. A. (1989). Tenascin: an extra-cellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol. 5, 71-92.
16. Frosch, B. A., Berquin, I., Emmert-Buck, M. R., Moin, K., and Sloane, B. F (1999). Molecular regulation, membrane association and secretion of tumor cathepsin B. APMIS 107, 28-37.
17. Gundersen, D., Tran-Thang, C., Sorda, B., Mourali, F, and Ruegg, C. (1997). Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J. Immunol. 158, 1051-1060.
18. Higuchi, M., Ohnishi, T., Arita, N., Hiraga, S., and Hayakawa, T. (1993). Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol. 85, 481-487.
19. Howeedy, A. A., Virtanen, I., Laitinen, L., Gould, M. S., Koukolis, G. K., and Gould, V. E. (1990). Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab. Invest. 63, 798-806.
20. Jahkola, T., Toivonen, T., von Smitten, K., Blomqvist, C., and Virtanen, I. (1996). Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int. J. Cancer 69, 445-447.
21. Jahkola, T., Toivonen, T., Nordling, S., von Smitten, K., and Virtanen, I. (1998). Expression of tenascin-C in intraductal carcinoma of human breast: relationship to invasion. Eur. J. Cancer 11, 1687-1692.
22. Jallo, G. I., Friedlander, D. R., Kelly, P. J., Wisoff, J. H., Grumet, M., and Zagzag, D. (1997). Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis. Neurosurgery 41, 1052-1059.
23. Kim, C.H., Bak, K.H., Kim, Y.S., Kim, J.M., Ko, Y., Oh, S.J., Kim, K.M., and Hong, E.K. (2000). Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg. Neurol. 54, 235-240.
24. Koukoulis, G. K., Gould, V. E., Bhattacharyya, A., Could, J. E. Howeedy, A. A., and Virtanen, I. (1991). Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum. Pathol. 22, 636-643.
25. Kusagawa, H., Onoda, K., Namikawa, S., Yada, I., Okada, A., and Yoshida, T. (1998). Expression and degeneration of tenascin-C in human lung cancers. Br. J. Cancer 77, 98-102.
26. Lah, T. T., Buck, M. R., Honn, K. V., Crissman, J. D., Rao, N. C., Liotta, L. A., and Sloane, B. F. (1989). Degradation of laminin by human tumor cathepsin B. Clin. Expl. Metastasis 7, 461-468.
27. Linebaugh, B.E., Sameni, M., Day, N.A., Sloane, B.F., and Keppler, D. (1999). Exocytosis of active cathepsin B: enzyme activity at pH 7.0, inhibition and molecular mass. Eur. J. Biochem. 264, 100-109.
28. Liotta, L. A., Rao, C. N., and Wewer, U. M. (1986). Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem. 55, 1037-1057.
29. Mackie, E. J., Thesleff, I., and Liverani, D. (1988a). Induction of tenascin in healing wounds. J. Cell Biol. 107, 2757-2767.
30. Mackie, E.J., Tucker, R. P., Halfer, W., Chiquet-Ehrismann, R., and Epperlein, H. H. (1988b). The distribution of tenascin coincides with pathways of neural crest cell migration. Development 102, 237-250.
31. Mai, J., Finley, R. L., Waisman, D. M., and Sloane, B. F. (2000a). Procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275, 12806-12812.
32. Mai, J., Waisman, D. M., and Sloane, B. F. (2000b). Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim. Biophys. Acta 1477, 215-230.
33. Mignatti, P., Robbins, E., and Rifkin, D. B. (1986). Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47, 487-498.
34. Mikkelsen, T., Yan, P. S., Ho, K. L., Sameni, M., Sloane, B. F., and Rosenblum, M. L. (1995). Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J. Neurosurg. 83, 285-290.
35. Moin, K., Day, N. A., Sameni, M., Hasnain, S., Hirama, T., and Sloane, B. F. (1992). Human tumour cathepsin B: comparison with normal human liver cathepsin B. Biochem. J. 285, 427-434.
36. Natali, P.G., Nicotra, M. R., and Bigotti, A. (1991). Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int. J. Cancer 47, 811-816.
37. Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K., and Sekiguchi, K. (1991). Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res. 51, 4876-4881.
38. Podobnik, M., Kuhelj, R., Turk, V., and Turk, D. (1997). Crystal structure of the wild-type human procathepsin B at 2.5 Å resolution reveals the native active site of a papain-like cysteine protease zymogen. J. Mol. Biol. 271, 774-788.
39. Ramos, D. M., Chen, B. L., Boylen, K., Stern, M., Kramer, R. H., Sheppard, D., Nishimura, S. L., Greenspan, D., Zardi, L., and Pytela, R. (1997). Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-C. Int. J. Cancer 72, 369-376.
40. Ramos, D. M., Chen, B. L., Regezi, J., Zardi, L., and Pytela, R. (1998). Tenascin-C matrix assembly in oral squamous cell carcinoma. Int. J. Cancer 75, 680-687.
41. Riedl, S., Kadmon, M., Tandara, A., Hinz, U., Moller, P., and Faissner, A. (1997). Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa. Anti-cancer Res. 17, 3165-3166.
42. Sakakura, T., and Kusakabe, M. (1994). Can tenascin be redundant in cancer development? Perspect. Dev. Neurobiol. 2, 111-116.
43. Sameni, M., Elliott, E., Ziegler, G., Fortgens, P. H., Dennison, C., and Sloane, B. F. (1995). Cathepsins B and D are localized at surface of human breast cancer cells. Pathol. Oncol. Res. 1, 43-53.
44. Schnapp, L. M., Hatch, N., Ramos, D. M., Klimanskaya, I. V., Sheppard, D., and Pytela, R. (1995). The human integrin α8β1 functions as a receptor for tenascin, fibronectin, and vitronectin. J. Biol. Chem. 270, 23196-23202.
45. Shintani, S, Alcalde, R. E., Matsumura, T., and Terakado, N. (1997). Extracellular matrices expression in invasion area of adenoid cystic carcinoma of salivary glands. Cancer Lett. 116, 9-14.
46. Shoji, T., Kamiya, T., Tsubura, A., Hamada, Y., Hatano, T., Hioki, K., and Morii, S. (1993). Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J. Surg. Res. 55, 295-297.
47. Siri, A., Knauper, V., Veirana, N., Caocci, F., Murphy, G., and Zardi, L. (1995). Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J. Biol. Chem. 270, 8650-8654.
48. Sloane, B. F., Rozhin, J., Johnson, K., Taylor, H., Crissman, J. D., and Honn, K. V. (1986). Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA 83, 2483-2487.
49. Vaidya, P., Yosida, T., Sakakura, T., Yatani, R., Noguchi, T., and Kawarada, Y. (1996). Combined analysis of expression of cerbB-2, Ki-67 antigen, and tenascin provides a better prognostic indicator of carcinoma of the papilla of Vater. Pancreas 12, 196-201.
50. Ventimiglia, J. B., Wikstrand, C. J., Ostrowski, L. E., Bourdon, M. A., Lightner, V. A., and Bigner, D. D. (1992). Tenascin expression in human glioma cell lines and normal tissues. J. Neuroimmunol. 36, 41-55.
51. Verstraeten, A.A., Mackie, E.J., Hageman, P.C., Hilgers, J., Schol, D.J., and De Jongh, G. J. (1992). Tenascin expression in basal cell carci-noma. Br. J. Dermatol. 127, 571-574.
52. Wallner, K., Li, C., Shah, P. K., Fishbein, M.C., Forrester, J.S., Kaul, S., and Sharifi, B.G. (1999). Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation 99, 1284-1289.
53. 2+- and phospholipid-binding annexins. J. Cell. Phys. 144, 511-522.
54. Xue, Y., Smedts, F., Latijnhouwers, M. A., Ruijter, E., Aalders, T. W., Rosette, J., Ebruyne, F. M. J., and Schalken, J. A. (1998). Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. Br. J. Urol. 81, 844-851.
55. Zagzag, D., Friedlander, D. R., Miller, D. C., Dosik, J., Cangiarella, J., Kostianovsky, M., Cohen, H., Grumet, M., and Greco, M. A. (1995). Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 55, 907-914.
56. Zagzag, D., Friedlander, D. R., Dosik, J., Chikramane, S., Chan, W., Greco, M. A., Allen, J. C., Dorovini-Zis, K., and Grumet, M. (1996). Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vivo. Cancer Res. 56, 182-189.